Efficacy of Submucosal Tramadol and Lidocaine on Success Rate of Inferior Alveolar Nerve Block in Mandibular Molars with Symptomatic Irreversible Pulpitis
- Conditions
- patients with symptomatic irreversible pulpitisIrreversible pulpitismandibular molarlidocainesupplemental anesthesiasubmucosal injectiontramadol
- Registration Number
- TCTR20190509004
- Lead Sponsor
- none
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 105
1. A single mandibular molar tooth responding to cold test for a long time and diagnosed with symptomatic irreversible pulpitis
2. Patients with preoperative pain scores ranging from moderate to severe (55â€170 mm) on a Heft-Parker visual analog scale (HP VAS, 0â€170 mm)
3. The absence of periapical radiolucency on periapical radiography (except enlarged periodontal ligaments not larger than 0.75-1 mm)
4. Have the ability to understand the informed consent form and pain record scales to be used within the study
1. Receiving analgesic or anti-inflammatory drugs within 24 hours prior to treatment
2. Allergy or susceptibility to any opioid or nonopioid analgesia, including lidocaine, tramadol or NSAIDs
3. Pregnant or nursing, those with any bleeding problem or those using anticoagulant medication
4. Patients have not lip numbness following initial IANB injection
4. In addition to hypersensitive teeth to percussion and palpation; teeth have calcified root canals, periodontal diseases, root resorption, open apex, necrotic pulp and have already been undergone root canal treatment were excluded from the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method pulpal anesthesia 15 minutes HP VAS Scale
- Secondary Outcome Measures
Name Time Method preparation pain 15 minutes HP VAS Scale